Triage Standards During Pandemic May Worsen Racial Disparities in Treatment
Two Yale-led studies suggest that a standard measurement designed to help predict which patients have the best chances of survival—and who therefore should receive treatment—could promote racial disparities of treatment outcomes.Source: YaleNews
Empowering Black Girls May Help to Reduce Drug Use, YSPH Study Finds
Black girls make up a relatively small portion of the overall drug-using population. But their health consequences are more severe than most: Reproductive issues, fertility issues, sexually transmitted infections and trauma exposure are all obstacles they face at statistically higher rates compared to their peers.
Improving the Diagnosis of Heart Disease in Women
Dr. Samit Shah is leading a team to demonstrate the effectiveness of validated, but not widely administered procedures for the many women who have reduced blood flow to the heart without blocked arteries or cholesterol build-up often associated with heart disease.
Yale Cancer Center Study Shows New Drug Combinations Improve Outcomes for Patients With Advanced Lung Cancer
New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer.
Major Federal Translational Science Support Is Renewed for Yale School of Medicine
Yale School of Medicine has been awarded nearly $63.7 million over the next five years from the National Center for Advancing Translational Sciences to renew its five-year Clinical and Translational Science Award (CTSA) to accelerate research discoveries that can have a positive impact on health.
Have You Considered Genetic Screening To Identify Your Health Risks?
At Yale, a project called “Generations” is performing a 10-gene analysis to provide people with information about their risk for 10 diseases, all of them heart- or cancer-related. Anyone is eligible and the analysis is free of charge.Source: Yale Medicine
Study Examines Severe Breakthrough Cases of COVID-19
These patients tended to be older—between 65 and 95 with a median age of 80.5—and had preexisting comorbidities, such as cardiovascular disease and type 2 diabetes. A subset of patients was also on immunosuppressive drugs that may affect vaccine efficacy.Source: YaleNews
Immune Cell Betrayal Explains Why It Gets Colder as We Age
With age, people become more susceptible to cold as inflammation and metabolic problems which can lead to a host of chronic diseases. Researchers at Yale and the University of California-San Francisco have found one culprit in this process — the same immune cells within fat that are designed to protect us from cold temperatures.Source: YaleNews
RNA Science at Yale Gets a Boost From Steitz Donation
Joan A. Steitz, PhD, has donated her portion of the prestigious Wolf Prize—which she received in February 2021—to the Yale Center for RNA Science and Medicine. The $33,000 donation will be used to start a Yale RNA Scholars Program in support of junior RNA scientists.
Yale doctor on CT’s positivity rate nearing 5%, latest research on Moderna’s vaccine, unvaccinated discouraged from Labor Day travel
Yale Infectious Disease expert, Dr. Onyema Ogbuagu discusses CT’s positivity rate nearing 5%, latest research on Moderna’s vaccine, unvaccinated discouraged from Labor Day travelSource: WTNH
Yale Study: High Schoolers Who Vape Prefer Flavors That Produce Cooling Sensation
More than half of Connecticut high schoolers who currently vape chose flavors that produce a cooling sensation in the mouth and throat. These flavors may be associated with using nicotine and vaping more frequently, according to a new study by Yale researchers.
Yale Geneticist With Rare Disease to Build Pediatric Cell Atlas of Skeletal Muscle
A $3 million grant from the Chan Zuckerberg Initiative, awarded to a team of researchers led by Monkol Lek, PhD, assistant professor of genetics at Yale, will support Lek and his team in creating a Pediatric Cell Atlas of Skeletal Muscle — a roadmap of healthy skeletal cells and how they change at four key age group milestones between the ages of zero and 18 years.